Marcelo A. Nobrega to Genetic Predisposition to Disease
This is a "connection" page, showing publications Marcelo A. Nobrega has written about Genetic Predisposition to Disease.
Connection Strength
0.723
-
An in vivo cis-regulatory screen at the type 2 diabetes associated TCF7L2 locus identifies multiple tissue-specific enhancers. PLoS One. 2012; 7(5):e36501.
Score: 0.216
-
Genome-wide association and multi-omics studies identify MGMT as a novel risk gene for Alzheimer's disease among women. Alzheimers Dement. 2023 03; 19(3):896-908.
Score: 0.109
-
Identification of atrial fibrillation associated genes and functional non-coding variants. Nat Commun. 2019 10 18; 10(1):4755.
Score: 0.091
-
TCF7L2 is a master regulator of insulin production and processing. Hum Mol Genet. 2014 Dec 15; 23(24):6419-31.
Score: 0.063
-
Enhancers: five essential questions. Nat Rev Genet. 2013 04; 14(4):288-95.
Score: 0.058
-
In vitro scan for enhancers at the TCF7L2 locus. Diabetologia. 2013 Jan; 56(1):121-5.
Score: 0.056
-
Modulation ofTcf7l2 expression alters behavior in mice. PLoS One. 2011; 6(10):e26897.
Score: 0.052
-
Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Res. 2011 Sep; 21(9):1417-25.
Score: 0.051
-
African-specific alleles modify risk for asthma at the 17q12-q21 locus in African Americans. Genome Med. 2022 09 29; 14(1):112.
Score: 0.028